Abstract |
Pneumatosis intestinalis is a rare but known potential complication of treatment with cetuximab. Here we present two cases of pneumatosis intestinalis occurring in patients who were receiving cetuximab as treatment for advanced head and neck cancer. In both cases, cetuximab was discontinued after discovery of the pneumatosis intestinalis.
|
Authors | James A Miller, Daniel J Ford, Mohamed S Ahmed, Thom R Loree |
Journal | Case reports in oncological medicine
(Case Rep Oncol Med)
Vol. 2015
Pg. 214236
( 2015)
ISSN: 2090-6706 [Print] United States |
PMID | 26294992
(Publication Type: Journal Article)
|